Clinical and molecular features of POLG-related mitochondrial disease

Jeffrey D Stumpf, Russell P Saneto, William C Copeland, Jeffrey D Stumpf, Russell P Saneto, William C Copeland

Abstract

The inability to replicate mitochondrial genomes (mtDNA) by the mitochondrial DNA polymerase (pol γ) leads to a subset of mitochondrial diseases. Many mutations in POLG, the gene that encodes pol γ, have been associated with mitochondrial diseases such as myocerebrohepatopathy spectrum (MCHS) disorders, Alpers-Huttenlocher syndrome, myoclonic epilepsy myopathy sensory ataxia (MEMSA), ataxia neuropathy spectrum (ANS), and progressive external ophthalmoplegia (PEO). This chapter explores five important topics in POLG-related disease: (1) clinical symptoms that identify and distinguish POLG-related diseases, (2) molecular characterization of defects in polymerase activity by POLG disease variants, (3) the importance of holoenzyme formation in disease presentation, (4) the role of pol γ exonuclease activity and mutagenesis in disease and aging, and (5) novel approaches to therapy and avoidance of toxicity based on primary research in pol γ replication.

References

    1. Aitken H, Gorman G, McFarland R, Roberts M, Taylor RW, Turnbull DM 2009. Clinical reasoning: Blurred vision and dancing feet: Restless legs syndrome presenting in mitochondrial disease. Neurology 72: e86–90
    1. Ameur A, Stewart JB, Freyer C, Hagstrom E, Ingman M, Larsson NG, Gyllensten U 2011. Ultra-deep sequencing of mouse mitochondrial DNA: mutational patterns and their origins. PLoS Genet 7: e1002028.
    1. Bailey CM, Kasiviswanathan R, Copeland WC, Anderson KS 2009a. R964C mutation of DNA polymerase γ imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother 53: 2610–2612
    1. Bailey LJ, Cluett TJ, Reyes A, Prolla TA, Poulton J, Leeuwenburgh C, Holt IJ 2009b. Mice expressing an error-prone DNA polymerase in mitochondria display elevated replication pausing and chromosomal breakage at fragile sites of mitochondrial DNA. Nucleic Acids Res 37: 2327–2335
    1. Baruffini E, Lodi T 2010. Construction and validation of a yeast model system for studying in vivo the susceptibility to nucleoside analogues of DNA polymerase γ allelic variants. Mitochondrion 10: 183–187
    1. Baruffini E, Lodi T, Dallabona C, Puglisi A, Zeviani M, Ferrero I 2006. Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. Hum Mol Genet 15: 2846–2855
    1. Baruffini E, Ferrero I, Foury F 2007. Mitochondrial DNA defects in Saccharomyces cerevisiae caused by functional interactions between DNA polymerase γ mutations associated with disease in human. Biochim Biophys Acta 1772: 1225–1235
    1. Baruffini E, Horvath R, Dallabona C, Czermin B, Lamantea E, Bindoff L, Invernizzi F, Ferrero I, Zeviani M, Lodi T 2011. Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model. Mitochondrion 11: 182–190
    1. Bicknese AR, May W, Hickey WF, Dodson WE 1992. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 32: 767–775
    1. Blok MJ, Van den Bosch BJ, Jongen E, Hendrickx A, de Die-Smulders CE, Hoogendijk JE, Brusse E, de Visser M, Poll-The BT, Bierau J, et al. 2009. The unfolding clinical spectrum of POLG mutations. J Med Genet 46: 776–785
    1. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chretien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, et al. 2007. Mutation of RRM2B, encoding p53–controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39: 776–780
    1. Chan SS, Copeland WC 2009. DNA polymerase γ and mitochondrial disease: Understanding the consequence of POLG mutations. Biochim Biophys Acta 1787: 312–319
    1. Chan SSL, Longley MJ, Copeland WC 2005a. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem 280: 31341–31346
    1. Chan SSL, Longley MJ, Naviaux RK, Copeland WC 2005b. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome. DNA Repair 4: 1381–1389
    1. Chan SSL, Longley MJ, Copeland WC 2006. Modulation of the W748S mutation in DNA polymerase γ by the E1143G polymorphism in mitochondrial disorders. Hum Mol Genet 15: 3473–3483
    1. Chinnery PF, Zeviani M 2008. 155th ENMC workshop: Polymerase γ and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands. Neuromuscul Disord 18: 259–267
    1. Cohen BH, Naviaux RK 2010. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 51: 364–373
    1. Cohen BH, Chinnery PF, Copeland WC 2010. POLG-related disorders. In Gene reviews at gene tests: Medical genetics information resource (), University of Washington, Seattle, WA
    1. Copeland WC 2008. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 59: 131–146
    1. Dai DF, Chen T, Wanagat J, Laflamme M, Marcinek DJ, Emond MJ, Ngo CP, Prolla TA, Rabinovitch PS 2010. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9: 536–544
    1. de Vries MC, Rodenburg RJ, Morava E, van Kaauwen EP, Ter Laak H, Mullaart RA, Snoeck IN, van Hasselt PM, Harding P, van den Heuvel LP, et al. 2007. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase γ (POLG1) mutations. Eur J Pediatr 166: 229–234
    1. Di Fonzo A, Bordoni A, Crimi M, Sara G, Bo RD, Bresolin N, Comi GP 2003. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 22: 498–499
    1. Dimmock D, Tang LY, Schmitt ES, Wong LJ 2010. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 56: 1119–1127
    1. Edgar D, Shabalina I, Camara Y, Wredenberg A, Calvaruso MA, Nijtmans L, Nedergaard J, Cannon B, Larsson NG, Trifunovic A 2009. Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice. Cell Metab 10: 131–138
    1. Engelsen BA, Tzoulis C, Karlsen B, Lillebo A, Laegreid LM, Aasly J, Zeviani M, Bindoff LA 2008. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain 131: 818–828
    1. Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR 1997. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49: 239–245
    1. Ferrari G, Lamantea E, Donati A, Filosto M, Briem E, Carrara F, Parini R, Simonati A, Santer R, Zeviani M 2005. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γ A. Brain 128: 723–731
    1. Gonzalez-Vioque E, Blazquez A, Fernandez-Moreira D, Bornstein B, Bautista J, Arpa J, Navarro C, Campos Y, Fernandez-Moreno MA, Garesse R, et al. 2006. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population. Arch Neurol 63: 107–111
    1. Gray H, Wong TW 1992. Purification and identification of subunit structure of the human mitochondrial DNA polymerase. J Biol Chem 267: 5835–5841
    1. Graziewicz MA, Longley MJ, Bienstock RJ, Zeviani M, Copeland WC 2004. Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. Nat Struct Mol Biol 11: 770–776
    1. Guo X, Kudryavtseva E, Bodyak N, Nicholas A, Dombrovsky I, Yang D, Kraytsberg Y, Simon DK, Khrapko K 2010. Mitochondrial DNA deletions in mice in men: Substantia nigra is much less affected in the mouse. Biochim Biophys Acta 1797: 1159–1162
    1. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Cohen BH 2007. Mitochondrial disease: A practical approach for primary care physicians. Pediatrics 120: 1326–1333
    1. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Wong LJ, Cohen BH, Naviaux RK 2008. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94: 16–37
    1. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, Goethem GV, Lofgren A, Hackman P, Paetau A, et al. 2005. Mitochondrial DNA polymerase W748S mutation: A common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77: 430–441
    1. Hance N, Ekstrand MI, Trifunovic A 2005. Mitochondrial DNA polymerase γ is essential for mammalian embryogenesis. Hum Mol Genet 14: 1775–1783
    1. Harding BN 1990. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): A personal review. J Child Neurol 5: 273–287
    1. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE, et al. 1994. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44: 721–727
    1. Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E, Prokisch H, Lochmuller H, McFarland R, Ramesh V, et al. 2006. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Brain 129: 1674–1684
    1. Kakuda TN 2000. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22: 685–708
    1. Kasiviswanathan R, Copeland WC 2011. Biochemical analysis of the G517V POLG variant reveals wild-type like activity. Mitochondrion 11: 929–934
    1. Kasiviswanathan R, Longley MJ, Chan SS, Copeland WC 2009. Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in MtDNA replication. J Biol Chem 284: 19501–19510
    1. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, et al. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481–484
    1. Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S, Papadimitriou A, Spelbrink H, Silvestri L, Casari G, et al. 2002. Mutations of mitochondrial DNA polymerase γ are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 52: 211–219
    1. Lecrenier N, Foury F 1995. Overexpression of the RNR1 gene rescues Saccharomyces cerevisiae mutants in the mitochondrial DNA polymerase-encoding MIP1 gene. Mol Gen Genet 249: 1–7
    1. Lee YS, Kennedy WD, Yin YW 2009. Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations. Cell 139: 312–324
    1. Lee YS, Lee S, Demeler B, Molineux IJ, Johnson KA, Yin YW 2010a. Each monomer of the dimeric accessory protein for human mitochondrial DNA polymerase has a distinct role in conferring processivity. J Biol Chem 285: 1490–1499
    1. Lee YS, Molineux IJ, Yin YW 2010b. A single mutation in human mitochondrial DNA polymerase pol γ A affects both polymerization and proofreading activities, but only as a holoenzyme. J Biol Chem 285: 28105–28116
    1. Lewis W, Day BJ, Kohler JJ, Hosseini SH, Chan SSL, Green E, Haase CP, Keebaugh E, Long R, Ludaway T, et al. 2007. MtDNA depletion, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γ. Lab Invest 87: 326–335
    1. Lim SE, Longley MJ, Copeland WC 1999. The mitochondrial p55 accessory subunit of human DNA polymerase γ enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J Biol Chem 274: 38197–38203
    1. Longley MJ, Prasad R, Srivastava DK, Wilson SH, Copeland WC 1998a. Identification of 5′-deoxyribose phosphate lyase activity in human DNA polymerase γ and its role in mitochondrial base excision repair in vitro. Proc Natl Acad Sci 95: 12244–12248
    1. Longley MJ, Ropp PA, Lim SE, Copeland WC 1998b. Characterization of the native and recombinant catalytic subunit of human DNA polymerase γ: Identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry 37: 10529–10539
    1. Longley MJ, Graziewicz MA, Bienstock RJ, Copeland WC 2005. Consequences of mutations in human DNA polymerase γ. Gene 354: 125–131
    1. Longley MJ, Humble MM, Sharief FS, Copeland WC 2010. Disease variants of the human mitochondrial DNA helicase encoded by C10orf2 differentially alter protein stability, nucleotide hydrolysis and helicase activity. J Biol Chem 285: 29690–29702
    1. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors PA, Rautakorpi I, Peltonen PL, Majamaa PK, et al. 2004. Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: Clinical and molecular genetic study. Lancet 364: 875–882
    1. Luoma PT, Luo N, Loscher WN, Farr CL, Horvath R, Wanschitz J, Kiechl S, Kaguni LS, Suomalainen A 2005. Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome. Hum Mol Genet 14: 1907–1920
    1. Milone M, Brunetti-Pierri N, Tang LY, Kumar N, Mezei MM, Josephs K, Powell S, Simpson E, Wong LJ 2008. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 18: 626–632
    1. Naviaux RK, Nguyen KV 2004. POLG Mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 55: 706–712
    1. Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, Haas RH 1999. Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers’ syndrome. Ann Neurol 45: 54–58
    1. Nguyen KV, Sharief F, Chan SSL, Copeland WC, Naviaux RK 2006. Molecular diagnosis of Alpers syndrome. J Hepatology 45: 108–116
    1. Nick McElhinny SA, Pavlov YI, Kunkel TA 2006. Evidence for extrinsic exonucleolytic proofreading. Cell Cycle 5: 958–962
    1. Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ, Bitner-Glindzicz M, Taylor RW, Laskowski A, Thorburn DR, et al. 2006. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase γ. Hum Reprod 21: 2467–2473
    1. Ponamarev MV, Longley MJ, Nguyen D, Kunkel TA, Copeland WC 2002. Active site mutation in DNA polymerase γ associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J Biol Chem 277: 15225–15228
    1. Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, Kujoth GC, et al. 2011. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci 108: 4135–4140
    1. Saneto RP, Naviaux RK 2010. Polymerase γ disease through the ages. Dev Disabil Res Rev 16: 163–174
    1. Saneto RP, Lee IC, Koenig MK, Bao X, Weng SW, Naviaux RK, Wong LJ 2010. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19: 140–146
    1. Sarzi E, Bourdon A, Chretien D, Zarhrate M, Corcos J, Slama A, Cormier-Daire V, de Lonlay P, Munnich A, Rotig A 2007. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr 150: 531–534, e531–e536
    1. Shrader WD, Amagata A, Barnes A, Enns GM, Hinman A, Jankowski O, Kheifets V, Komatsuzaki R, Lee E, Mollard P, et al. 2011. α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorg Med Chem Lett 21: 3693–3698
    1. Stuart GR, Santos JH, Strand MK, Van Houten B, Copeland WC 2006. Mitochondrial DNA defects in S. cerevisiae with mutations in DNA polymerase γ associated with progressive external ophthalmolplegia. Hum Mol Genet 15: 363–374
    1. Stumpf JD, Copeland WC 2011. Mitochondrial DNA replication and disease: Insights from DNA polymerase γ mutations. Cell Mol Life Sci 68: 219–233
    1. Stumpf JD, Bailey CM, Spell D, Stillwagon M, Anderson KS, Copeland WC 2010. mip1 Containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in Saccharomyces cerevisiae. Hum Mol Genet 19: 2123–2133
    1. Szczepanowska K, Foury F 2010. A cluster of pathogenic mutations in the 3′-5′ exonuclease domain of DNA polymerase γ defines a novel module coupling DNA synthesis and degradation. Hum Mol Genet 19: 3516–3529
    1. Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES, Craigen WJ, Zhang W, Wong LJ 2011. Mitochondrial DNA polymerase γ mutations: An ever expanding molecular and clinical spectrum. J Med Genet 48: 669–681
    1. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417–423
    1. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, Spelbrink JN, Wibom R, Jacobs HT, Larsson NG 2005. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci 102: 17993–17998
    1. Tulinius MH, Hagne I 1991. EEG findings in children and adolescents with mitochondrial encephalomyopathies: A study of 25 cases. Brain Dev 13: 167–173
    1. Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, Ferrari G, Aarseth JH, Bindoff LA 2006. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: A study of 26 cases. Brain 129: 1685–1692
    1. Uusimaa J, Hinttala R, Rantala H, Paivarinta M, Herva R, Roytta M, Soini H, Moilanen JS, Remes AM, Hassinen IE, et al. 2008. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia 49: 1038–1045
    1. Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C 2001. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nature Genet 28: 211–212
    1. Van Goethem G, Martin JJ, Dermaut B, Lofgren A, Wibail A, Ververken D, Tack P, Dehaene I, Van Zandijcke M, Moonen M, et al. 2003a. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13: 133–142
    1. Van Goethem G, Mercelis R, Lofgren A, Seneca S, Ceuterick C, Martin JJ, Van Broeckhoven C 2003b. Patient homozygous for a recessive POLG mutation presents with features of MERRF. Neurology 61: 1811–1813
    1. Van Goethem G, Luoma P, Rantamaki M, Al Memar A, Kaakkola S, Hackman P, Krahe R, Lofgren A, Martin JJ, De Jonghe P, et al. 2004. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63: 1251–1257
    1. Vermulst M, Bielas JH, Kujoth GC, Ladiges WC, Rabinovitch PS, Prolla TA, Loeb LA 2007. Mitochondrial point mutations do not limit the natural lifespan of mice. Nature Genet 39: 540–543
    1. Vermulst M, Wanagat J, Kujoth GC, Bielas JH, Rabinovitch PS, Prolla TA, Loeb LA 2008. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nature Genet 40: 392–394
    1. Vermulst M, Wanagat J, Loeb LA 2009. On mitochondria, mutations, and methodology. Cell Metab 10: 437.
    1. Walter MC, Czermin B, Muller-Ziermann S, Bulst S, Stewart JD, Hudson G, Schneiderat P, Abicht A, Holinski-Feder E, Lochmuller H, et al. 2010. Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. J Neurol 257: 1517–1523
    1. Williams SL, Huang J, Edwards YJ, Ulloa RH, Dillon LM, Prolla TA, Vance JM, Moraes CT, Zuchner S 2010. The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimers. Cell Metab 12: 675–682
    1. Winterthun S, Ferrari G, He L, Taylor RW, Zeviani M, Turnbull DM, Engelsen BA, Moen G, Bindoff LA 2005. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase γ mutations. Neurology 64: 1204–1208
    1. Wolf NI, Rahman S, Schmitt B, Taanman JW, Duncan AJ, Harting I, Wohlrab G, Ebinger F, Rating D, Bast T 2009. Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50: 1596–1607
    1. Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, Milone M, Cohen BH, Wical B, Ganesh J, et al. 2008. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29: E150–E172
    1. Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Takahashi T, Kimura S, Oka S 2007. Novel mutation of human DNA polymerase γ associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis 195: 1419–1425
    1. Zhang D, Mott JL, Chang SW, Denniger G, Feng Z, Zassenhaus HP 2000. Construction of transgenic mice with tissue-specific acceleration of mitochondrial DNA mutagenesis. Genomics 69: 151–161

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe